Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1992 1
1993 2
1994 2
1996 8
1997 1
1998 5
1999 8
2000 7
2001 4
2002 4
2003 5
2004 3
2005 5
2006 5
2007 7
2008 7
2009 9
2010 7
2011 11
2012 14
2013 5
2014 10
2015 11
2016 16
2017 19
2018 13
2019 15
2020 32
Text availability
Article attribute
Article type
Publication date

Search Results

223 results
Results by year
Filters applied: . Clear all
Page 1
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.
Molina JM, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro N. Molina JM, et al. Med Mal Infect. 2020 Jun;50(4):384. doi: 10.1016/j.medmal.2020.03.006. Epub 2020 Mar 30. Med Mal Infect. 2020. PMID: 32240719 Free PMC article. Clinical Trial. No abstract available.
Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process.
Tran DH, Sugamata R, Hirose T, Suzuki S, Noguchi Y, Sugawara A, Ito F, Yamamoto T, Kawachi S, Akagawa KS, Ōmura S, Sunazuka T, Ito N, Mimaki M, Suzuki K. Tran DH, et al. J Antibiot (Tokyo). 2019 Oct;72(10):759-768. doi: 10.1038/s41429-019-0204-x. Epub 2019 Jul 12. J Antibiot (Tokyo). 2019. PMID: 31300721
Our in vitro approaches indicated that progeny virus replication was remarkably inhibited by treating viruses with azithromycin before infection; however, azithromycin administration after infection did not affect this process. We next investigated the steps inhibit …
Our in vitro approaches indicated that progeny virus replication was remarkably inhibited by treating viruses with azithromycin befor …
Azithromycin induces anti-viral responses in bronchial epithelial cells.
Gielen V, Johnston SL, Edwards MR. Gielen V, et al. Eur Respir J. 2010 Sep;36(3):646-54. doi: 10.1183/09031936.00095809. Epub 2010 Feb 11. Eur Respir J. 2010. PMID: 20150207 Free article.
Previous evidence suggests that macrolide antibiotics have anti-inflammatory and antiviral effects; however, the mechanism is unknown. We investigated the anti-rhinoviral potential of macrolides through the induction of antiviral gene mRNA and protein. Primary human …
Previous evidence suggests that macrolide antibiotics have anti-inflammatory and antiviral effects; however, the mechanism is unknown …
Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo.
Zeng S, Meng X, Huang Q, Lei N, Zeng L, Jiang X, Guo X. Zeng S, et al. Int J Antimicrob Agents. 2019 Apr;53(4):362-369. doi: 10.1016/j.ijantimicag.2018.12.009. Epub 2018 Dec 30. Int J Antimicrob Agents. 2019. PMID: 30599241
Specific antiviral agents are not commercially available yet. Here we report that the macrolide antibiotics spiramycin (SPM) and azithromycin (AZM) possess antiviral activities against EV-A71 and CV-A16. ...
Specific antiviral agents are not commercially available yet. Here we report that the macrolide antibiotics spiramycin (SPM) a …
Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells.
Schögler A, Kopf BS, Edwards MR, Johnston SL, Casaulta C, Kieninger E, Jung A, Moeller A, Geiser T, Regamey N, Alves MP. Schögler A, et al. Eur Respir J. 2015 Feb;45(2):428-39. doi: 10.1183/09031936.00102014. Epub 2014 Oct 30. Eur Respir J. 2015. PMID: 25359346 Free article.
The macrolide antibiotic azithromycin has antiviral properties in human bronchial epithelial cells. We investigated the potential of azithromycin to induce antiviral mechanisms in CF bronchial epithelial cells. ...While stimulating antiviral res …
The macrolide antibiotic azithromycin has antiviral properties in human bronchial epithelial cells. We investigated the potent …
Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J, Choi JH, Chang MJ. Hahn J, et al. J Clin Pharm Ther. 2017 Dec;42(6):661-671. doi: 10.1111/jcpt.12636. Epub 2017 Sep 25. J Clin Pharm Ther. 2017. PMID: 28948652 Review.
In this review, we discussed changes in the PK of antibiotic, antiviral, antituberculosis and antifungal agents administered to adult patients on ECMO. ...The PK of vancomycin, piperacillin-tazobactam, meropenem, azithromycin, amikacin and caspofungin did not …
In this review, we discussed changes in the PK of antibiotic, antiviral, antituberculosis and antifungal agents administered t …
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells.
Iannetta M, Ippolito G, Nicastri E. Iannetta M, et al. Antimicrob Agents Chemother. 2017 Aug 24;61(9):e01152-17. doi: 10.1128/AAC.01152-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28839081 Free PMC article. No abstract available.
Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation.
Menzel M, Akbarshahi H, Tufvesson E, Persson C, Bjermer L, Uller L. Menzel M, et al. Oncotarget. 2017 May 9;8(19):31601-31611. doi: 10.18632/oncotarget.16364. Oncotarget. 2017. PMID: 28415826 Free PMC article.
Knockdown of MDA5 and RIG-I by siRNA showed involvement of MDA5 but not RIG-I in azithromycin's IFN-inducing effects in vitro. ...Similarly, azithromycin induced MDA5-associated IFN in virally stimulated lungs in vivo exclusively in allergic mice. Effects of …
Knockdown of MDA5 and RIG-I by siRNA showed involvement of MDA5 but not RIG-I in azithromycin's IFN-inducing effects in vitro. …
Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.
Li C, Zu S, Deng YQ, Li D, Parvatiyar K, Quanquin N, Shang J, Sun N, Su J, Liu Z, Wang M, Aliyari SR, Li XF, Wu A, Ma F, Shi Y, Nielsevn-Saines K, Jung JU, Qin FX, Qin CF, Cheng G. Li C, et al. Antimicrob Agents Chemother. 2019 Sep 16;63(12):e00394-19. doi: 10.1128/AAC.00394-19. Online ahead of print. Antimicrob Agents Chemother. 2019. PMID: 31527024 Free PMC article.
Azithromycin (AZM) is a widely used antibiotic, with additional antiviral and anti-inflammatory properties that remain poorly understood. ...These findings highlight the potential use of AZM as a broad antiviral agent to combat viral infection and prevent ZIK
Azithromycin (AZM) is a widely used antibiotic, with additional antiviral and anti-inflammatory properties that remain poorly
223 results
Jump to page
Feedback